Prevalence, Socio-demographic and Clinical Predictors of Post-diagnostic Utilisation of Different Types of Complementary and Alternative Medicine (CAM) in a Nationwide Cohort of Danish Women Treated for Primary Breast Cancer
Overview
Affiliations
Aim: This study investigated the prevalence and predictors of use of complementary and alternative medicine (CAM) in a nationwide inception cohort of Danish women treated for early-stage breast cancer as well as differences in user patterns for individual types of CAM.
Methods: Use of CAM since the time of diagnosis was assessed 12-16 weeks post-surgery for the 3343 women (age 18-70) included in the study (response rate: 68%). Socio-demographic and clinical variables were obtained from national longitudinal registries.
Results: 40.1% of the women had used one or more types of CAM. Users were younger than non-users. Age adjusted analyses showed that CAM users were characterised by absence of comorbidity, higher educational level, higher personal income, higher social status, being divorced/separated and living in the metropolitan area of Copenhagen. Multivariate analyses revealed that chemotherapy was the only clinical and treatment-related predictor of CAM use, and that CAM users were more likely to be of normal weight and non-smokers. Of CAM users, 33.7% believed that CAM would have a positive influence upon their breast cancer. Different characteristics distinguished users of individual types of CAM.
Conclusion: The results of this first nationwide study of utilisation of CAM in breast cancer show that CAM users are healthier and more likely to have higher socio-economic status than non-users. Different user patterns for individual types of CAM may be overlooked, when different types of CAM are treated as one homogeneous category.
Krejbich P, Birringer M Antioxidants (Basel). 2022; 11(11).
PMID: 36358521 PMC: 9686580. DOI: 10.3390/antiox11112149.
Agdal R Integr Cancer Ther. 2022; 21:15347354221118328.
PMID: 36154510 PMC: 9520151. DOI: 10.1177/15347354221118328.
Stie M, Delmar C, Norgaard B, Jensen L BMJ Open. 2022; 12(4):e059960.
PMID: 35470199 PMC: 9039403. DOI: 10.1136/bmjopen-2021-059960.
Morrissey A, ONeill A, OSullivan K, Robinson K Br J Pain. 2022; 16(1):109-118.
PMID: 35111319 PMC: 8801684. DOI: 10.1177/20494637211023293.
Asiimwe J, B Nagendrappa P, Atukunda E, Kamatenesi M, Nambozi G, Tolo C Evid Based Complement Alternat Med. 2021; 2021:9963038.
PMID: 34055029 PMC: 8149249. DOI: 10.1155/2021/9963038.